Omicron News and Research

RSS
Vaccine component BNT162b4 enhances T-cell immunity against SARS-CoV-2 variants for reduced COVID-19 disease severity

Vaccine component BNT162b4 enhances T-cell immunity against SARS-CoV-2 variants for reduced COVID-19 disease severity

17 Apr 2023
Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19

Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19

17 Apr 2023
How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

15 Apr 2023
Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

15 Apr 2023
Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults

Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults

15 Apr 2023
Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

14 Apr 2023
Bivalent COVID-19 boosters provide durable, effective protection against omicron subvariants

Bivalent COVID-19 boosters provide durable, effective protection against omicron subvariants

13 Apr 2023
The virological characteristics of XBB.1.16

The virological characteristics of XBB.1.16

12 Apr 2023
The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity

The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity

12 Apr 2023
SARS-CoV-2 infection among infants born to maternal COVID-19 cases during Omicron variant predominance

SARS-CoV-2 infection among infants born to maternal COVID-19 cases during Omicron variant predominance

12 Apr 2023
New insights into how Omicron variants avoid destruction by "killer" T cells

New insights into how Omicron variants avoid destruction by "killer" T cells

11 Apr 2023
Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

11 Apr 2023
Newly discovered antibody appears to block infection by all dominant variants of SARS-CoV-2 virus

Newly discovered antibody appears to block infection by all dominant variants of SARS-CoV-2 virus

7 Apr 2023
Research finds SARS-CoV-2 Omicron variant to be more fatal than seasonal influenza

Research finds SARS-CoV-2 Omicron variant to be more fatal than seasonal influenza

7 Apr 2023
Nasal SARS-CoV-2 vaccine outperforms existing vaccines in preclinical trial

Nasal SARS-CoV-2 vaccine outperforms existing vaccines in preclinical trial

6 Apr 2023
mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants

mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants

6 Apr 2023
Long COVID's significant impact on health calls for greater consideration in pandemic policy planning

Long COVID's significant impact on health calls for greater consideration in pandemic policy planning

6 Apr 2023
Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

5 Apr 2023
Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

5 Apr 2023
The association between neutralizing antibody response breadth and long COVID symptoms

The association between neutralizing antibody response breadth and long COVID symptoms

5 Apr 2023

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback